PremiumCompany AnnouncementsImugene Limited Announces Cessation of Restricted Stock Units Imugene Limited Issues New Restricted Stock Units to Employees Imugene Limited Announces Investor Webinar to Discuss Business Updates PremiumCompany AnnouncementsImugene Appoints Darren Keamy as CFO and Company Secretary Imugene Secures Indian Patent for CF33 Oncolytic Virotherapy Imugene Secures Patent for OnCARlytics in China, Strengthening Market Position PremiumCompany AnnouncementsImugene Reports Key Milestones in Cancer Trials and Financial Strengthening Imugene Limited Adjusts Securities Portfolio with Cessation of Restricted Stock Units Imugene Limited Announces Quotation of New Securities on ASX